{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:24:35Z","timestamp":1761819875389,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.prro.2018.12.007","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T00:02:52Z","timestamp":1550016172000},"page":"128-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Erlotinib-Associated Rash Exacerbated by Whole-Brain Radiation Therapy: A Patient's Case Report"],"prefix":"10.1016","volume":"9","author":[{"given":"Alexander K.","family":"Erikson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan Y.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janina T.","family":"Sheedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Staci N.","family":"Shoudis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshita R.","family":"Paripati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence T.","family":"Sio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2018.12.007_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000371821","article-title":"Acnei-form rash induced by EGFR inhibitors: Review of the literature and new insights","volume":"1","author":"Fabbrocini","year":"2015","journal-title":"Skin Appendage Disord"},{"key":"10.1016\/j.prro.2018.12.007_bib2","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/neuonc\/not114","article-title":"Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: A randomized, double-blind, placebo-controlled trial","volume":"15","author":"Brown","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.prro.2018.12.007_bib3","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.critrevonc.2017.10.011","article-title":"Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review","volume":"120","author":"Bonomo","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.prro.2018.12.007_bib4","doi-asserted-by":"crossref","first-page":"e1004969","DOI":"10.1080\/23723556.2015.1004969","article-title":"Mechanisms underlying skin disorders induced by EGFR inhibitors","volume":"2","author":"Holcmann","year":"2015","journal-title":"Mol Cell Oncol"},{"key":"10.1016\/j.prro.2018.12.007_bib5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jaad.2013.02.025","article-title":"Erlotinib-related skin toxicities: Treatment strategies in patients with metastatic non-small cell lung cancer","volume":"69","author":"Kiyohara","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.prro.2018.12.007_bib6","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1200\/JCO.2004.11.057","article-title":"Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer","volume":"22","author":"P\u00e9rez-Soler","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2018.12.007_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4149\/neo_2013_004","article-title":"Skin rash as useful marker of erlotinib efficacy in NSCLC and its impact on clinical practice","volume":"60","author":"Fiala","year":"2013","journal-title":"Neoplasma"},{"key":"10.1016\/j.prro.2018.12.007_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.canrad.2014.12.001","article-title":"Systemic treatment of brain metastases from lung cancer","volume":"19","author":"Barlesi","year":"2015","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.prro.2018.12.007_bib9","doi-asserted-by":"crossref","first-page":"5807346","DOI":"10.1155\/2016\/5807346","article-title":"Combining whole-brain radiotherapy with gefitinib\/erlotinib for brain metastases from non-small-cell lung cancer: A meta-analysis","volume":"2016","author":"Zheng","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.prro.2018.12.007_bib10","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/ijc.28290","article-title":"The theoretical foundation and research progress for WBRT combined with erlotinib for the treatment of multiple brain metastases in patients with lung adenocarcinoma","volume":"133","author":"Zhuang","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.prro.2018.12.007_bib11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ijrobp.2015.02.005","article-title":"Adding erlotinib to chemoradiation improves overall survival but not progression-free survival in stage III non-small-cell lung cancer","volume":"92","author":"Komaki","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.12.007_bib12","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.ijrobp.2010.12.035","article-title":"Prospective study of epidermal growth factor receptor tyrosine kinase inhibitors concurrent with individualized radiotherapy for patients with locally advanced or metastatic non\u2013small-cell lung cancer","volume":"81","author":"Wang","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.12.007_bib13","doi-asserted-by":"crossref","first-page":"57310","DOI":"10.18632\/oncotarget.9809","article-title":"A phase II study of concurrent chemoradiotherapy and erlotinib for inoperable esophageal squamous cell carcinoma","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prro.2018.12.007_bib14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2217\/fon.14.269","article-title":"Erlotinib-associated rash in patients with EGFR mutation-positive non-small-cell lung cancer treated in the EURTAC trial","volume":"11","author":"de Marinis","year":"2015","journal-title":"Future Oncol"},{"key":"10.1016\/j.prro.2018.12.007_bib15","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2147\/DDDT.S53011","article-title":"Phase II study of whole brain radiotherapy with or without erlotinib in patients with multiple brain metastases from lung adenocarcinoma","volume":"7","author":"Zhuang","year":"2013","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.prro.2018.12.007_bib16","first-page":"106","article-title":"Randomized trial of erlotinib plus whole-brain radiotherapy for NSCLC patients with multiple brain metastases","volume":"16","author":"Lee","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.prro.2018.12.007_bib17","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.7314\/APJCP.2013.14.10.5699","article-title":"Clinical observation of whole brain radiotherapy concomitant with targeted therapy for brain metastasis in non-small cell lung cancer patients with chemotherapy failure","volume":"14","author":"Cai","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.prro.2018.12.007_bib18","first-page":"524","article-title":"Evaluation of gefitinib plus radiotherapy in non-small-cell lung cancer patients with brain metastases","volume":"92","author":"Fu","year":"2012","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.prro.2018.12.007_bib19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ejca.2011.10.016","volume":"48","author":"Pesce","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.prro.2018.12.007_bib20","first-page":"893","article-title":"Effects of gefitinib combined with whole brain radiation on brain metastasis from non-small-cell lung cancer","volume":"10","author":"Wu","year":"2012","journal-title":"Chinese J Genl Pract"},{"key":"10.1016\/j.prro.2018.12.007_bib21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3747\/co.v18i3.877","article-title":"Managing treatment-related adverse events associated with EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer","volume":"18","author":"Hirsh","year":"2011","journal-title":"Curr Oncol"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850018303631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850018303631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:21:57Z","timestamp":1761819717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850018303631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1879850018303631"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2018.12.007","relation":{},"ISSN":["1879-8500"],"issn-type":[{"type":"print","value":"1879-8500"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erlotinib-Associated Rash Exacerbated by Whole-Brain Radiation Therapy: A Patient's Case Report","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2018.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}